ANIP · Healthcare · $1.7B
Pre-market $72.650.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“매출은 2억6천6백만 달러로 전년 동기 대비 26%, 전 분기 2억3천7백만 달러에서 12% 늘며 다시 가속됐고, 코트로핀은 1억1천7백만 달러”
In the company's words · 2026 2분기 earnings call